Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma

Pathogenic variants in TBK1, MYOC, and OPTN are associated with primary open-angle glaucoma (POAG) with severe visual field defects. This study aims to understand further POAG-related pathogenic variant(s) based on a cohort of East Asian populations that have not been well-characterized. We conducte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genetics in Medicine Open 2024, Vol.2, p.100839, Article 100839
Hauptverfasser: Shiga, Yukihiro, Hashimoto, Kazuki, Fujita, Kosuke, Maekawa, Shigeto, Sato, Kota, Kubo, Shintaroh, Kawase, Kazuhide, Tokumo, Kana, Kiuchi, Yoshiaki, Mori, Sotaro, Nakamura, Makoto, Iwata, Takeshi, Nishiguchi, Koji M., Nakazawa, Toru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 100839
container_title Genetics in Medicine Open
container_volume 2
creator Shiga, Yukihiro
Hashimoto, Kazuki
Fujita, Kosuke
Maekawa, Shigeto
Sato, Kota
Kubo, Shintaroh
Kawase, Kazuhide
Tokumo, Kana
Kiuchi, Yoshiaki
Mori, Sotaro
Nakamura, Makoto
Iwata, Takeshi
Nishiguchi, Koji M.
Nakazawa, Toru
description Pathogenic variants in TBK1, MYOC, and OPTN are associated with primary open-angle glaucoma (POAG) with severe visual field defects. This study aims to understand further POAG-related pathogenic variant(s) based on a cohort of East Asian populations that have not been well-characterized. We conducted a comprehensive screening of TBK1, MYOC, and OPTN variants in 174 POAG Japanese patients, followed by 8380 population-specific genome sequencing data references, segregation analysis, and functional protein assays to determine pathogenic variants. Despite the small sample size, 4 variants were novel, 2 of which p.(Cys5Trp) and p.(Thr293Met) were in the MYOC gene, and 2 p.(Asn51Thr), and p.(Gln142His) were in the OPTN. Notably, the OPTN p.(Asn51Thr) missense variant adjacent to the p.(Glu50Lys) variant, a well-known POAG pathogenic variant, was segregated from all proband’s family members with POAG. Moreover, in silico and in vitro analyses revealed that the OPTN p.(Asn51Thr) protein increased binding instability, interactions of the OPTN-TBK1 complex, and enhanced protein insolubility, likewise the p.(Glu50Lys) protein. Our findings may provide further genetic insights into rare variants of POAG and support the clear conclusion that OPTN p.(Asn51Thr) is a novel likely pathogenic variant. [Display omitted]
doi_str_mv 10.1016/j.gimo.2023.100839
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11613796</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2949774423008488</els_id><sourcerecordid>3146665800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2529-3b818d195df599f450439ecffcc49ef8a558560104d47d8645987610c7432a683</originalsourceid><addsrcrecordid>eNp9kUtr3DAUhUVpaUKSP9BF0TJdeCJZD0ulUIbQRyA0WUy2FYp85dFgS67kGei_r4eZhmSTlS7Suece3Q-hD5QsKKHyarPowpAWNanZfEEU02_Qaa25rpqG87fP6hN0UcqGEFLrmjVMvkcnTEuphVan6PdNC3EKPjg7hRRx8vjufvULj4vLZYmCrtb502e8xDHtoMejndapgxgc3tkcbJxwiHjMYbD5L04jxMrGrgfc9Xbr0mDP0Ttv-wIXx_MMPXz_trr-Wd3e_bi5Xt5Wrha1rtijoqqlWrReaO25IJxpcN47xzV4ZYVQQhJKeMubVkk-Z28kJa7hrLZSsTP09eA7bh8HaN38p2x7c0xmkg3m5UsMa9OlnaFUUtZoOTtcHh1y-rOFMpkhFAd9byOkbTGMcimlUITM0vogdTmVksE_zaHE7OGYjdnDMXs45gBnbvr4POFTy38Us-DLQQDznnYBsikuQHTQhgxuMm0Kr_n_A45cn0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146665800</pqid></control><display><type>article</type><title>Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma</title><source>DOAJ Directory of Open Access Journals</source><creator>Shiga, Yukihiro ; Hashimoto, Kazuki ; Fujita, Kosuke ; Maekawa, Shigeto ; Sato, Kota ; Kubo, Shintaroh ; Kawase, Kazuhide ; Tokumo, Kana ; Kiuchi, Yoshiaki ; Mori, Sotaro ; Nakamura, Makoto ; Iwata, Takeshi ; Nishiguchi, Koji M. ; Nakazawa, Toru</creator><creatorcontrib>Shiga, Yukihiro ; Hashimoto, Kazuki ; Fujita, Kosuke ; Maekawa, Shigeto ; Sato, Kota ; Kubo, Shintaroh ; Kawase, Kazuhide ; Tokumo, Kana ; Kiuchi, Yoshiaki ; Mori, Sotaro ; Nakamura, Makoto ; Iwata, Takeshi ; Nishiguchi, Koji M. ; Nakazawa, Toru ; Japan Glaucoma Society Omics Group (JGS-OG)</creatorcontrib><description>Pathogenic variants in TBK1, MYOC, and OPTN are associated with primary open-angle glaucoma (POAG) with severe visual field defects. This study aims to understand further POAG-related pathogenic variant(s) based on a cohort of East Asian populations that have not been well-characterized. We conducted a comprehensive screening of TBK1, MYOC, and OPTN variants in 174 POAG Japanese patients, followed by 8380 population-specific genome sequencing data references, segregation analysis, and functional protein assays to determine pathogenic variants. Despite the small sample size, 4 variants were novel, 2 of which p.(Cys5Trp) and p.(Thr293Met) were in the MYOC gene, and 2 p.(Asn51Thr), and p.(Gln142His) were in the OPTN. Notably, the OPTN p.(Asn51Thr) missense variant adjacent to the p.(Glu50Lys) variant, a well-known POAG pathogenic variant, was segregated from all proband’s family members with POAG. Moreover, in silico and in vitro analyses revealed that the OPTN p.(Asn51Thr) protein increased binding instability, interactions of the OPTN-TBK1 complex, and enhanced protein insolubility, likewise the p.(Glu50Lys) protein. Our findings may provide further genetic insights into rare variants of POAG and support the clear conclusion that OPTN p.(Asn51Thr) is a novel likely pathogenic variant. [Display omitted]</description><identifier>ISSN: 2949-7744</identifier><identifier>EISSN: 2949-7744</identifier><identifier>DOI: 10.1016/j.gimo.2023.100839</identifier><identifier>PMID: 39669598</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Genetics ; Glaucoma ; Myocilin (MYOC) ; Optineurin (OPTN) ; TANK Binding Kinase 1 (TBK1)</subject><ispartof>Genetics in Medicine Open, 2024, Vol.2, p.100839, Article 100839</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors.</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2529-3b818d195df599f450439ecffcc49ef8a558560104d47d8645987610c7432a683</cites><orcidid>0000-0001-5531-7409</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,864,885,4023,27922,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39669598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shiga, Yukihiro</creatorcontrib><creatorcontrib>Hashimoto, Kazuki</creatorcontrib><creatorcontrib>Fujita, Kosuke</creatorcontrib><creatorcontrib>Maekawa, Shigeto</creatorcontrib><creatorcontrib>Sato, Kota</creatorcontrib><creatorcontrib>Kubo, Shintaroh</creatorcontrib><creatorcontrib>Kawase, Kazuhide</creatorcontrib><creatorcontrib>Tokumo, Kana</creatorcontrib><creatorcontrib>Kiuchi, Yoshiaki</creatorcontrib><creatorcontrib>Mori, Sotaro</creatorcontrib><creatorcontrib>Nakamura, Makoto</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Nishiguchi, Koji M.</creatorcontrib><creatorcontrib>Nakazawa, Toru</creatorcontrib><creatorcontrib>Japan Glaucoma Society Omics Group (JGS-OG)</creatorcontrib><title>Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma</title><title>Genetics in Medicine Open</title><addtitle>Genet Med Open</addtitle><description>Pathogenic variants in TBK1, MYOC, and OPTN are associated with primary open-angle glaucoma (POAG) with severe visual field defects. This study aims to understand further POAG-related pathogenic variant(s) based on a cohort of East Asian populations that have not been well-characterized. We conducted a comprehensive screening of TBK1, MYOC, and OPTN variants in 174 POAG Japanese patients, followed by 8380 population-specific genome sequencing data references, segregation analysis, and functional protein assays to determine pathogenic variants. Despite the small sample size, 4 variants were novel, 2 of which p.(Cys5Trp) and p.(Thr293Met) were in the MYOC gene, and 2 p.(Asn51Thr), and p.(Gln142His) were in the OPTN. Notably, the OPTN p.(Asn51Thr) missense variant adjacent to the p.(Glu50Lys) variant, a well-known POAG pathogenic variant, was segregated from all proband’s family members with POAG. Moreover, in silico and in vitro analyses revealed that the OPTN p.(Asn51Thr) protein increased binding instability, interactions of the OPTN-TBK1 complex, and enhanced protein insolubility, likewise the p.(Glu50Lys) protein. Our findings may provide further genetic insights into rare variants of POAG and support the clear conclusion that OPTN p.(Asn51Thr) is a novel likely pathogenic variant. [Display omitted]</description><subject>Genetics</subject><subject>Glaucoma</subject><subject>Myocilin (MYOC)</subject><subject>Optineurin (OPTN)</subject><subject>TANK Binding Kinase 1 (TBK1)</subject><issn>2949-7744</issn><issn>2949-7744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kUtr3DAUhUVpaUKSP9BF0TJdeCJZD0ulUIbQRyA0WUy2FYp85dFgS67kGei_r4eZhmSTlS7Suece3Q-hD5QsKKHyarPowpAWNanZfEEU02_Qaa25rpqG87fP6hN0UcqGEFLrmjVMvkcnTEuphVan6PdNC3EKPjg7hRRx8vjufvULj4vLZYmCrtb502e8xDHtoMejndapgxgc3tkcbJxwiHjMYbD5L04jxMrGrgfc9Xbr0mDP0Ttv-wIXx_MMPXz_trr-Wd3e_bi5Xt5Wrha1rtijoqqlWrReaO25IJxpcN47xzV4ZYVQQhJKeMubVkk-Z28kJa7hrLZSsTP09eA7bh8HaN38p2x7c0xmkg3m5UsMa9OlnaFUUtZoOTtcHh1y-rOFMpkhFAd9byOkbTGMcimlUITM0vogdTmVksE_zaHE7OGYjdnDMXs45gBnbvr4POFTy38Us-DLQQDznnYBsikuQHTQhgxuMm0Kr_n_A45cn0A</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Shiga, Yukihiro</creator><creator>Hashimoto, Kazuki</creator><creator>Fujita, Kosuke</creator><creator>Maekawa, Shigeto</creator><creator>Sato, Kota</creator><creator>Kubo, Shintaroh</creator><creator>Kawase, Kazuhide</creator><creator>Tokumo, Kana</creator><creator>Kiuchi, Yoshiaki</creator><creator>Mori, Sotaro</creator><creator>Nakamura, Makoto</creator><creator>Iwata, Takeshi</creator><creator>Nishiguchi, Koji M.</creator><creator>Nakazawa, Toru</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5531-7409</orcidid></search><sort><creationdate>2024</creationdate><title>Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma</title><author>Shiga, Yukihiro ; Hashimoto, Kazuki ; Fujita, Kosuke ; Maekawa, Shigeto ; Sato, Kota ; Kubo, Shintaroh ; Kawase, Kazuhide ; Tokumo, Kana ; Kiuchi, Yoshiaki ; Mori, Sotaro ; Nakamura, Makoto ; Iwata, Takeshi ; Nishiguchi, Koji M. ; Nakazawa, Toru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2529-3b818d195df599f450439ecffcc49ef8a558560104d47d8645987610c7432a683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Genetics</topic><topic>Glaucoma</topic><topic>Myocilin (MYOC)</topic><topic>Optineurin (OPTN)</topic><topic>TANK Binding Kinase 1 (TBK1)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shiga, Yukihiro</creatorcontrib><creatorcontrib>Hashimoto, Kazuki</creatorcontrib><creatorcontrib>Fujita, Kosuke</creatorcontrib><creatorcontrib>Maekawa, Shigeto</creatorcontrib><creatorcontrib>Sato, Kota</creatorcontrib><creatorcontrib>Kubo, Shintaroh</creatorcontrib><creatorcontrib>Kawase, Kazuhide</creatorcontrib><creatorcontrib>Tokumo, Kana</creatorcontrib><creatorcontrib>Kiuchi, Yoshiaki</creatorcontrib><creatorcontrib>Mori, Sotaro</creatorcontrib><creatorcontrib>Nakamura, Makoto</creatorcontrib><creatorcontrib>Iwata, Takeshi</creatorcontrib><creatorcontrib>Nishiguchi, Koji M.</creatorcontrib><creatorcontrib>Nakazawa, Toru</creatorcontrib><creatorcontrib>Japan Glaucoma Society Omics Group (JGS-OG)</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Genetics in Medicine Open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shiga, Yukihiro</au><au>Hashimoto, Kazuki</au><au>Fujita, Kosuke</au><au>Maekawa, Shigeto</au><au>Sato, Kota</au><au>Kubo, Shintaroh</au><au>Kawase, Kazuhide</au><au>Tokumo, Kana</au><au>Kiuchi, Yoshiaki</au><au>Mori, Sotaro</au><au>Nakamura, Makoto</au><au>Iwata, Takeshi</au><au>Nishiguchi, Koji M.</au><au>Nakazawa, Toru</au><aucorp>Japan Glaucoma Society Omics Group (JGS-OG)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma</atitle><jtitle>Genetics in Medicine Open</jtitle><addtitle>Genet Med Open</addtitle><date>2024</date><risdate>2024</risdate><volume>2</volume><spage>100839</spage><pages>100839-</pages><artnum>100839</artnum><issn>2949-7744</issn><eissn>2949-7744</eissn><abstract>Pathogenic variants in TBK1, MYOC, and OPTN are associated with primary open-angle glaucoma (POAG) with severe visual field defects. This study aims to understand further POAG-related pathogenic variant(s) based on a cohort of East Asian populations that have not been well-characterized. We conducted a comprehensive screening of TBK1, MYOC, and OPTN variants in 174 POAG Japanese patients, followed by 8380 population-specific genome sequencing data references, segregation analysis, and functional protein assays to determine pathogenic variants. Despite the small sample size, 4 variants were novel, 2 of which p.(Cys5Trp) and p.(Thr293Met) were in the MYOC gene, and 2 p.(Asn51Thr), and p.(Gln142His) were in the OPTN. Notably, the OPTN p.(Asn51Thr) missense variant adjacent to the p.(Glu50Lys) variant, a well-known POAG pathogenic variant, was segregated from all proband’s family members with POAG. Moreover, in silico and in vitro analyses revealed that the OPTN p.(Asn51Thr) protein increased binding instability, interactions of the OPTN-TBK1 complex, and enhanced protein insolubility, likewise the p.(Glu50Lys) protein. Our findings may provide further genetic insights into rare variants of POAG and support the clear conclusion that OPTN p.(Asn51Thr) is a novel likely pathogenic variant. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39669598</pmid><doi>10.1016/j.gimo.2023.100839</doi><orcidid>https://orcid.org/0000-0001-5531-7409</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2949-7744
ispartof Genetics in Medicine Open, 2024, Vol.2, p.100839, Article 100839
issn 2949-7744
2949-7744
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11613796
source DOAJ Directory of Open Access Journals
subjects Genetics
Glaucoma
Myocilin (MYOC)
Optineurin (OPTN)
TANK Binding Kinase 1 (TBK1)
title Identification of OPTN p.(Asn51Thr): A novel pathogenic variant in primary open-angle glaucoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A33%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20OPTN%20p.(Asn51Thr):%20A%20novel%20pathogenic%20variant%20in%20primary%20open-angle%20glaucoma&rft.jtitle=Genetics%20in%20Medicine%20Open&rft.au=Shiga,%20Yukihiro&rft.aucorp=Japan%20Glaucoma%20Society%20Omics%20Group%20(JGS-OG)&rft.date=2024&rft.volume=2&rft.spage=100839&rft.pages=100839-&rft.artnum=100839&rft.issn=2949-7744&rft.eissn=2949-7744&rft_id=info:doi/10.1016/j.gimo.2023.100839&rft_dat=%3Cproquest_pubme%3E3146665800%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146665800&rft_id=info:pmid/39669598&rft_els_id=S2949774423008488&rfr_iscdi=true